Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer
PET/CT with the new <sup>68</sup>Ga-labeled minigastrin analog DOTA-dGlu-Ala-Tyr-Gly-Trp-(<i>N</i>-Me)Nle-Asp-1-Nal-NH<sub>2</sub> (<sup>68</sup>Ga-DOTA-MGS5) was performed on patients with advanced medullary thyroid cancer (MTC) to evaluate cholecysto...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | ingelesa |
| Argitaratua: |
2023
|
| Sarrera elektronikoa: | https://doi.org/10.2967/jnumed.122.264977 https://jnm.snmjournals.org/content/jnumed/64/6/859.full.pdf |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|